SEC Form 4 · accession 0001127602-15-009036
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davide Molho
Officer — Corporate Executive VP
Period of report
Feb 27, 2015
Accepted (ET)
Mar 2, 2015 · 2:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | A | 5,588 | $0.00 | A | 44,645 | D | |
| Common Stock | Feb 28, 2015 | F | 1,135 | $76.67 | D | 43,510 | D | |
| Common Stock | holding | — | — | — | 574 | I | By Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F2 | $76.67 | Feb 27, 2015 | A | 24,660 | A | Feb 27, 2016 | Feb 27, 2020 | Common Stock | 24,660 | 24,660 | D |
Explanation of responses
- F1Consists of 5,588 unvested restricted stock units that vest equally over four (4) years beginning one (1) year from the date of issuance.
- F2Stock options vest equally over four (4) years beginning one (1) year from date of grant.